LAWRENCE LETELLIER: Open Payments
NPI 1245834597 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$288 in 10 payments from 6 companies in 2025. Trend: 2023 $699 · 2024 $563 · 2025 $288
Food & beverage: $288
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $151 |
| Novo Nordisk Inc | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Medtronic, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $19 |
| Amgen Inc. | 1 | $18 |
Products named: SHINGRIX, INTELLIS ADAPTIVESTIM, Wegovy, BREZTRI, Cologuard Collection Kit, REPATHA, Ozempic, FARXIGA.
Industry payments across TX — which companies pay providers there.
